Real-life treatment patterns and medication costs in patients with hypertension treated with ramipril monotherapy or ramipril loose and fixed combinations in Poland
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2015, Vol 8, Issue 2
Abstract
Background: Real-World Evidence (RWE) provides insights into patient outcomes reflecting current practices under existing healthcare system conditions. Longitudinal patient data are a source of information that can be used to track treatments for anonymised individual patients over time. Arterial hypertension is one of the most common chronic diseases in Poland, leading to serious complications, especially if undiagnosed and not properly controlled. Fixed-dose combinations of antihypertensive drugs become more and more popular in the treatment of hypertension. The objective of this study was to analyze real-life treatment patterns and medication costs in patients with hypertension treated with the most popular ACEI in Poland - ramipril, in monotherapy, loose and fixed combinations. Methods: This analysis was based on the longitudinal prescription database (IMS “LRx”) of individual, anonymized patients structured by product, prescribing doctor specialty and patient age group and sex, sourced from dispensing transactions of 3367 chain and non-chain pharmacies, in the Polish open-care market. The period of analysis covers 20 months (January 2014 – August 2015). It is based on 1 488 053 patients and 9 023 582 prescriptions. Cost calculations were performed from payer’s and patient’s perspectives. Results: Owing to the availability of multiple treatment options, patterns in hypertension treatment in Poland are very complex, even when considered only at the molecule level. Furthermore, switching to fixed-dose combination therapy based on ramipril resulted in savings for patients as well as the public payer. Conclusion: Wider use of fixed-dose combinations is a cost saving option both for patients and the public payer.
Authors and Affiliations
Marcin Czech, Zbigniew Jasiński, Dominika Krupa
Keywords
Related Articles
- EP ID EP192165
- DOI 10.7365/JHPOR.2015.2.4
- Views 112
- Downloads 0
Aging society: organization of long-term care for the elderly in Poland.
Background: Aging society is one of the main challenges of the organization and provision of health care in XXI century. In 2030 more than one third of Polish population will be older than 65 years old and every tenth...
Assessment of thrombocytopenia symptoms using vignettes. Preliminary report on the development and implementation of a new instrument
Objective: Our aim was to create a vignette enabling the assessment of the impact of thrombocytopenia symptoms on patients’ quality of life. Methods: The vignettes which we created are focused on thrombocytopenia sym...
The combination of angiotensin converting enzyme inhibitors, diuretics and non-steroidal anti-inflammatory drugs in the routine community pharmacy settings in Poland: The unrecognized problem of ‘Triple Whammy’. A pilot analysis.
Background: ‘Triple Whammy’ defined as a combination of angiotensin converting enzyme inhibitors/angiotensin receptor antagonist, diuretics and non-steroidal anti-inflammatory drugs remains an important clinical problem,...
The disposal of unused and/or out of date medications in the community pharmacy setting in Poland – a challenge for pharmaceutical public health and pharmaceutical care
It has been proven that even small concentrations of certain drugs in the environment can be toxic to plants, but also fatal for animals and humans. The only proper way to prevent this phenomenon is to minimize the adver...
Comparator outcomes profile: need for an informed assessment of secondary outcomes for conducting post-launch observational studies in the HE&OR setting
Secondary clinical and health outcomes provide additional value and help drug molecule distinguish itself from competitor molecules. Comparator outcomes profile (COP) document in health economics and outcomes research (H...